1 / 23

Global Measles and Rubella Strategic Plan 2011-2020

elom
Télécharger la présentation

Global Measles and Rubella Strategic Plan 2011-2020

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


    1. Global Measles and Rubella Strategic Plan 2011-2020 This strategic plan is a work in progress, and the final plan will be available before the end of the year.This strategic plan is a work in progress, and the final plan will be available before the end of the year.

    2. Strategic Advisory Group of Experts (SAGE), November 2010 Measles can and should be eradicated Measurable progress towards 2015 global targets and existing regional elimination goals is required before establishing a target date Requested frequent updates on progress

    3. World Health Assembly, May 2011 2015 Global Targets as milestones towards eradication Vaccination coverage of 90% national level and 80% in every district Reported incidence of <5 cases of measles per million Mortality reduction of 95% vs. year 2000 ? Targets aligned with the 2015 Millennium Development Goal of reducing child mortality by 2/3 WHA 2010 endorsed 3 global measles targets as milestones towards eradication WHA 2010 endorsed 3 global measles targets as milestones towards eradication

    4. What is New? The plan includes: rubella and CRS control/elimination activities to strengthen routine immunization and disease surveillance systems. outbreak preparedness and response research and development reduction & eventual elimination of cases of rubella and CRS - renewed commitment from MI partners to allocate resources and provide technical assistance to strengthen routine immunization & surveillance Builds on > 10 years of experience implementing previous strategic plans. Incorporates the 2009 and 2010 guidance and recommendations from the WHO SAGE and the WHO Ad Hoc Global Measles Advisory Group. R&D is now one of the components of the strategy reduction & eventual elimination of cases of rubella and CRS - renewed commitment from MI partners to allocate resources and provide technical assistance to strengthen routine immunization & surveillance Builds on > 10 years of experience implementing previous strategic plans. Incorporates the 2009 and 2010 guidance and recommendations from the WHO SAGE and the WHO Ad Hoc Global Measles Advisory Group. R&D is now one of the components of the strategy

    5. Vision A world without measles, rubella and congenital rubella syndrome Reaching this vision will most likely happen beyond 2020Reaching this vision will most likely happen beyond 2020

    6. Goals By end 2015: Reduce global measles mortality by >95% compared to 2000 level Achieve regional measles and rubella/CRS elimination goals By end 2020: Achieve measles elimination in at least 5 WHO regions Achieve & sustain measles elimination in at least four WHO regions. PAHO, EURO, EMRO & WPRO Achieve rubella and CRS elimination in at least 2 WHO regions PAHO & EURO These are in line with the current regional measles & rubella targets Achieve & sustain measles elimination in at least four WHO regions. PAHO, EURO, EMRO & WPRO Achieve rubella and CRS elimination in at least 2 WHO regions PAHO & EURO These are in line with the current regional measles & rubella targets

    7. Measles and Rubella Elimination Goals by WHO Region, August 2011

More Related